Weight loss drugs like Ozempic and Wegovy are more popular than ever, leading people to seek options that are quicker, cheaper and involve less prying questions than a traditional in-person doctor visit.

But here’s a statistic that should give you pause: Casey Zaring, RPh, PharmD, a clinical pharmacist at OSF HealthCare, says a 2023 audit by the U.S. Food and Drug Administration [FDA] found 95% of online pharmacies were not legitimate. This leads to concerns about getting bilked out of money or taking a counterfeit drug that could bring serious side effects.

“It skips a lot of checks and balances,” Zaring says of the online outlets. For one, he says, these websites typically don’t have a pharmacist check your full medical history to make sure you’re getting the right drug.

Legit or not?

Some red flags to look for when deciding to buy prescription drugs online:

• Is the website based outside the United States?
  
• Do you start on one website and get pushed to another to complete the transaction?
  
• Does the site guarantee you cost savings? Zaring says it may look like a deal up front, but the final price tag might not be so good. Or, you might unintentionally sign up for auto-renewals. Zaring recommends first checking to see if your insurance will cover a medication.
  
• Have other people or agencies flagged the outlet for possible problems? Zaring recommends the websites safe.pharmacy and BeSafeRx to check if the pharmacy is registered with the National Association of Boards of Pharmacies and complying with the law.
  
  “How we know an online pharmacy is legal is they require a prescription by a licensed practitioner. You have a pharmacist review things, and the consumer has access to a pharmacist to ask questions,” Zaring explains. “Look for the outlet to be based in the United States and have a license in your state. Some online pharmacies will provide medications for patients even though they don’t have a license in the patient's state.”

Another law pharmacies have to follow is the Drug Supply Chain Security act. Zaring says this ensures all medications are logged and accounted for as they move from the manufacturer to the distributor. This makes sure all medications in the supply chain are legitimate and safe.

“In December 2025, the Food and Drug Administration warned about fake Ozempic,” Zaring recalls, noting what can go wrong if laws aren’t followed. “It looked almost identical to real Ozempic. It had lot numbers and expiration dates. But what they had done is created a syringe that looked similar and put on fake stickers.

“What pharmacists do then is go through and scan every medication that enters the pharmacy to ensure it’s directly from the manufacturer,” Zaring adds.

Consequences

Zaring says pharmacists’ biggest fear with these websites is someone putting something non-legitimate or harmful in their bodies. Is the syringe sterile? Has the drug expired? Is the dose correct? Is it properly diluted? Is it interacting with my other medications? Ingesting fake medications could lead to infections or other serious side effects.

Speaking on weight loss drugs: “If something is off by a decimal point, it’s a tenfold error. It can cause lack of movement in your gastrointestinal tract, obstructions and gallbladder attacks,” Zaring says. “If a person isn’t aware of the risks and talking to a pharmacist, they can upgrade their dose too quickly and cause more adverse effects like dehydration. Also with some of these online websites, there’s not continuous monitoring by a health care provider. No labs, check-ins or follow ups.

“The cost saving may be up front, but at the back end there may be an overall greater cost of having to see more health care providers because of adverse reactions or infections,” Zaring also warns.

If you’ve done business with an online pharmacy and have concerns, Zaring recommends talking to your primary care provider or a pharmacist at an in-person, well-recognized business. You can even bring the medication for them to inspect. You can also report pharmacies to the FDA at the BeSafeRx website.

Learn more

Read more about how OSF HealthCare pharmacists bring medication to you safely on the OSF HealthCare website. Some OSF HealthCare locations also have retail pharmacies that can be used regardless of whether you’re an OSF patient.

Interview clips

Frequently asked questions

Carla Richardson of Beverly on the southwest side of Chicago loves it when her grandson tells her, “You’re lookin’ fresh Nonnie!” She jokes, “This is what 77 looks like. But then again, I’m an old hippie.”

Richardson also credits her "fresh look” to her positive attitude and the consistent care she’s been receiving at OSF CompleteCare 55+. The clinic at 99^th and Western Avenue in Evergreen Park opened a year ago this month. It offers a new kind of primary care targeting older adults with ongoing health conditions who are looking for community, hands-on care and 24/7 access to real providers, not chatbots.

For Richardson, the vibe is great.

“They’re glad to see you. You don’t feel like you’re a patient. You feel like you’re going somewhere where someone really cares about you. They keep in touch with you, which is so important. I get texts from Taylor [Taylor Wen, PA, her OSF CompleteCare 55+provider] on MyChart, and it’s just an interaction that is rare.” 

Richardson was diagnosed four years ago with pulmonary sarcoidosis, and she has a history of pulmonary embolism and pneumonia. Plus, she has to be on blood thinners. Frustrated with her previous care, she tried OSF Complete Care 55+ shortly after it opened, and she’s been thrilled with her experience.

“My first experience with Taylor was just phenomenal. She was knowledgeable, patient, and she seemed like she cared. And going to doctors, sometimes you're just a patient number. And I didn't feel that here.”

Wen, a physician assistant, also sent Richardson to get a bone density scan where Richardson learned she had severe osteoporosis – so bad that she had to reduce the weight of her purse for fear it would break her wrist. Richardson is so grateful because she believes knowledge is power.

Staying connected to consistent care

Although she doesn’t consider herself computer savvy, Richardson says she’s learned to use OSF MyChart, and it keeps her connected to Wen.

“It’s easy to use, and it helps me monitor and keep up with my own health issues. I like the fact it reminds me when I have appointments coming up. I’m retired but I’m still busy.” 

Richardson remembers when doctors made house calls and says the care she’s getting now reminds her of that.

“When the doctor would come to your house with his bag. I know it was 100 years ago. But it’s so personal now, here. And you go to other places, and you’re waiting and waiting. And no one really seems to care.” 

The 6,300 square-foot clinic features 12 exam rooms and on-site labs. Sandy Valino Stock, DO, medical director of OSF CompleteCare 55+, says many people enjoy the option to connect digitally 24/7. Virtual visits make it easy to get answers to questions, especially after hours when symptoms aren’t severe enough for emergency care. Richardson says that kind of convenience could save her from long waits in the emergency department, only to be sent home with a quick evaluation and remedy.

Dr. Valino Stock says about half of the people who use the clinic take advantage of virtual visits, while the other half are seen in-person.

“Patients love the virtual concept because they don’t have to miss as much work. It’s just convenient for them,” Dr. Valino Stock shares. “Sometimes it’s a case where the patient comes into the clinic and their loved one wants to be tuned in, but they’re at work. So, they can be virtual during that visit, and they can be present if they need to be.” 

More than half of the clinic’s patients have high blood pressure and/or high cholesterol, one-fourth have diabetes and significant osteoarthritis, and about 10% have heart failure.

But consistent care is helping improve those conditions. For example, almost 80% of patients are now meeting blood pressure and A1c targets, up from 34% and 58% respectively.

The clinic has also seen success in increasing completion rates for screenings such as mammograms, bone density tests and colonoscopies. These preventive steps are often overlooked, but they play a key role in long-term health.

GLP1 medication management is available

As people age, weight management can also become more difficult as metabolism naturally slows. Dr. Valino Stock explains that metabolism typically declines by 1% to 2% each year after age 20. At CompleteCare 55+, more than half of patients are overweight or meet obesity criteria. This is important because extra weight on the body leads to most of the medical conditions being treated.

GLP-1 medications such as Mounjaro or Ozempic are, as Dr. Valino Stock put it, “magical” in helping people lose weight. But the GLP-1 journey requires regular check-ins and medication management.

“We see them monthly for the most part as they’re getting started on these GLP-1s. So, patients have better success at getting healthier, whether it’s controlling their blood sugars or lowering their weight and doing it in a healthy manner where they can maintain their muscle and minimize the side effects.” 

Many who enroll in OSF CompleteCare 55+ are women in pre-menopause and menopause. The outlook for Hormone Replacement Therapy (HRT) for menopause has fundamentally shifted in the past 10 years. Following major reviews, experts now recognize that for most healthy women under 60 or within 10 years of the onset of menopause, the benefits of HRT far outweigh the risks.

“If no contraindications, we can help women sleep better, have a little bit more energy, feel themselves and just continue life because life is very busy. So, if we can help a woman get a good night’s sleep, everything changes for that woman.” 

Beyond direct medical care, digital health care navigators at a “Connect Bar” in the lobby also help with insurance issues, coordinating appointments with specialists and navigating OSF MyChart and other tools to monitor their health. Events such as Tech Tuesday also allow for group sessions to address technology challenges.

Navigators also connect people with resources to address social needs such as transportation to appointments or senior centers or food insecurity. Through educational events with speakers on health topics and partnerships with local organizations, clinic leaders continue to learn more about the needs of the people they're serving.

Additionally, regular outreach efforts keep providers connected. For example, at the OSF CompleteCare 55+ clinic, any community member can access free blood pressure screenings from 10 a.m.-noon every first and third Tuesday of the month.

Learn more here about OSF CompleteCare 55+ primary care.

Video clips with Carla Richardson

Video clips with Dr. Sandy Valino Stock

B-roll-OSF CompleteCare 55+

It’s been two decades since the first-ever glucagon-like peptide-1 (GLP-1) medication was approved by the U.S. Food & Drug Administration (FDA).

For years, GLP-1s have been used to help those with diabetes. More recently, GLP-1 producers have begun marketing drugs like Ozempic®, Wegovy® (both semaglutide), Zepbound® or Mounjaro® (tirzepatide) for weight loss. Now heart health experts believe these medications can provide a robust benefit to heart health.

This comes as the American College of Cardiology® (ACC) released its five top trends in cardiovascular medicine in 2025, including “Anti-Obesity Drugs: Cardiovascular Benefit Beyond Weight Loss.”

The ACC reports that semaglutide and tirzepatide both “demonstrate remarkable cardiovascular benefits that extend beyond weight management.” Clinical trials show these medications can reduce the risk of major adverse cardiovascular events by up to 20% in patients with obesity and preexisting cardiovascular conditions.

Christopher Sparrow, MD, is an Advanced heart failure cardiologist with OSF HealthCare. He says he’s seen some remarkable benefits in many of his patients.

"The biggest thing I've seen in my practice is that patients who are obese can take these medications and have dramatic reductions in their weight, while doing it in a healthy fashion with a tolerable treatment," Dr. Sparrow says. "When these patients lose weight, they feel better, their blood pressure gets better, their cholesterol gets better, and their diabetes gets better if they have it. If they don't have it, their risk of getting diabetes goes down. Plus, their quality of life improves."

Dr. Sparrow is also the medical director of both the heart transplant program and adult heart unit at OSF HealthCare Saint Francis Medical Center, a Level 1 Trauma Center in Peoria, Illinois. He describes how GLP-1 drugs promote heart health.

"These medications target GLP-1 receptors. These receptors are primarily in the gastrointestinal system, but they're also in the brain and small amounts in the heart. We're learning more and more that these drugs can have direct impacts on the heart," Dr. Sparrow says. "Particularly in small blood vessels that are prone to effects of inflammation and disease in patients with obesity."

GLP-1s are also referred to as incretin analogues. Incretins are substances that promote insulin release to lower blood sugars. They act in the brain to increase the feeling of satiety (not being hungry anymore), which stops overeating and excessive drinking. Dr. Sparrow says the health benefits are both in how the medications are formulated, and because patients are losing weight. 

“Recent evidence has shown that in the obese population with heart failure, these drugs improve quality of life and improve the ability for these patients to function. That can mean being able to walk further distances," Dr. Sparrow says. "They lower systemic inflammation levels and reduce the risk of worsening heart failure events. For us, this is a brand-new tool in our toolbox to benefit the quality of life in these patients."

While GLP-1s are being seen as the heart’s newest best friend, on the flip side, obesity is one of its worst enemies.

"It (obesity) promotes higher blood pressure, diabetes, abnormal lipids and we know it increases inflammation in the body, which has adverse effects throughout the body," Dr. Sparrow says. "Simply by reducing obesity, we think we're making a huge impact on future cardiovascular risk."

Dr. Sparrow says doctors have known for a long time that patients with diabetes who use these forms of medications have a reduced risk of heart attack, stroke and death from cardiovascular causes like congestive heart failure. Now, that's expanding to patients who are obese or those with heart failure. 

Semaglutide and tirzepatide have been shown to have a better weight loss benefit compared to their GLP-1 predecessors, Dr. Sparrow says. Adding that these drugs can reduce cholesterol levels, improve hemoglobin A1C (a marker of diabetes), as well as lower blood pressure and markers of inflammation to a greater extent.

This treatment option can be used as primary and secondary prevention. That means people can take one of these drugs before anything like heart attack or stroke happens (primary), or after heart attack and stroke that could prevent another from happening (secondary). 

Patients with a body mass index (BMI) over 30, diabetes and/or cardiovascular disease are all patients that could benefit from this treatment, Dr. Sparrow says.

The struggle with getting these drugs to all the patients who want them comes down to two factors. 

1: Pharmacies can't stock enough to keep up with demand

2: Many insurance companies aren't covering these medications for weight loss

When it comes to obesity, Medicare recently announced it would cover these drugs for obese patients who have cardiovascular disease. It’s estimated this could impact roughly 3.4 million Americans.

Dr. Sparrow says it’s not surprising that over time researchers are finding health benefits for these drugs when it was previously meant for another purpose. He says it’s the natural order of scientific discovery that comes from a deeper understanding of these medications obtained through years of research and study. 

Video Interview Clips

Diabetes: a recap

Aminat Ogun, MD, a family medicine physician at OSF HealthCare, recaps Types 1 and 2 diabetes and where Type 1.5 fits in:

• Type 1: Dr. Ogun says the body’s immune system attacks insulin-producing cells in the pancreas.
  
  “Insulin is a hormone that brings glucose from food from the blood to the body’s cells for energy. So in Type 1 diabetes, the pancreas isn’t producing insulin,” Dr. Ogun explains. “This type of diabetes is usually seen in childhood and adolescence. It’s sudden onset. Symptoms are increased urination, increased thirst, weight loss and blurry vision. A lot of these people are dependent on insulin shots.”
   
• Type 2: The pancreas is producing insulin, but the body doesn’t recognize it. Dr. Ogun says these patients are typically age 40 and up, and the disease has a gradual onset.
  
  “Management is lifestyle modifications, like a healthy diet and physical activity,” Dr. Ogun says. “And there are medications to help control blood sugar like Metformin and Jardiance®, plus insulin shots.”
   
• Type 1.5: This is also called latent autoimmune diabetes in adults (LADA).
  
  “It’s a slow progressing form of Type 1 diabetes. It’s autoimmune like Type 1, but it’s usually seen in adults,” Dr. Ogun says. Symptoms are similar to Type 2 diabetes: fatigue, nausea and vomiting. Or, Dr. Ogun says some people may have little to no symptoms.

More on Type 1.5

So, if Type 1.5 diabetes can mimic Types 1 and 2, how do providers pin down a diagnosis?

Dr. Ogun says it’s something providers are learning more about and getting better at. She says providers will take a blood sample to look at your blood glucose and antibodies. Providers can also sample your blood or urine to look at your C-peptide level. C-peptide is a byproduct of insulin production, and if it’s low it’s cause for concern.

Treatment is similar to Type 2 diabetes: oral medication or an injectable GLP-1 medication like Ozempic®.

“But eventually once the autoimmune destruction happens, the person will need regular insulin,” Dr. Ogun says. “One good thing is that if you are aware the person might have Type 1.5, starting insulin earlier is a little bit better. Maybe that can preserve some of the cells in the pancreas and preserve some pancreas function.”

Shoring up your diet and exercise can also help.

Prevention

Dr. Ogun says since Type 1.5 diabetes is an autoimmune disease, there’s no bonafide way to prevent it. She adds there is a genetic component, meaning a child of someone with Type 1.5 is at a higher risk to get in themselves.

But, Dr. Ogun says sometimes education can be the best prevention. She says she’s happy Lance Bass has spoken out. Bass is active, fit and has diabetes – a sign that it can happen to anyone, and you should be aware of the disease.

Learn more

Read more about preventing and managing diabetes on the OSF HealthCare website.

Interview clips

Related stories

Prediabetes vs. diabetes: Pay attention to both
Managing holiday meals and diabetes
There's no magic weight loss drug

For those who don’t enjoy sleeping with what looks like the equivalent of a MiG fighter pilot mask, there’s possible relief with new medication approved to treat sleep apnea.

Sleep apnea is a disorder in which the airway either closes off completely or becomes so narrowed that breathing repeatedly stops and starts during sleep, often causing brief awakenings that disrupt restful sleep. A common treatment includes wearing a CPAP, or continuous positive airway pressure, mask to deliver air pressure into the airways to keep them open.

But now there’s a new option. The FDA recently approved tirzepatide (Zepbound) for adults with obesity and moderate-to-severe obstructive sleep apnea (OSA). The drug is typically prescribed for type 2 diabetes and is among the class of drugs known as GLP-1 receptor agonists, meaning they work on hormones that control appetite and insulin levels and can help promote weight loss.

Sarah Zallek, MD, a neurologist and vice president and chief medical officer for OSF HealthCare St. Joseph Medical Center in Bloomington, Illinois, is also medical director of OSF Sleep in Peoria. Dr. Zallek calls the approval of Zepbound for treatment of sleep apnea a significant and important development. She points out there have been few new developments for the treatment of OSA, and this is the first medication.

Could this let some people ditch their CPAP machines? Dr. Zallek says if their sleep apnea is caused by obesity, potentially yes.

“So, if you’re wearing CPAP and you have weight-related sleep apnea, weight loss is a great idea. The approval of Zepbound (tirzepatide) is a new avenue for us to look for treating overweight or obesity and to treat sleep apnea.”

Dr. Zallek says for some people with weight-related apnea, losing about 10% or more of overall body weight can significantly reduce or eliminate the sleeping disorder.  However, she warns that with GLP-1 agonists, it’s important to maintain a healthy diet and exercise because the medication carries significant risk of muscle loss.

 “It's really important for people who are using GLP-1s to maintain adequate nutritional intake, particularly with high quality protein, and maintain exercise, so that they get muscle resistance exercise and build and maintain muscle.”

Treatment of sleep apnea with CPAP is still the gold standard. Dr. Zallek says if switching to Zepbound to address sleep apnea, a doctor should continue to monitor weight loss and then test again to see if a person’s airway has opened up.

“Keep using that treatment until you successfully lose weight and get rid of the sleep apnea. It's not time to stop the CPAP and switch to Zepbound, for example. To treat sleep apnea, it's time to continue what you're doing, approach weight loss and then see if the sleep apnea has resolved.”

Studies have shown that people who have lost weight with GLP-1 drugs, tend to regain the weight once they quit taking the medication. This is because GLP-1s mimic natural hormones that regulate blood sugar, slow digestion, and make you feel full. So, Dr. Zallek stresses the need for lifestyle changes regardless of the approach to treating sleep apnea.

Dr. Zallek is board certified in Lifestyle Medicine, which means she incorporates therapeutic lifestyle interventions to treat and reverse chronic conditions. That includes a whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connections.

It’s possible other GLP-1 drug makers for Wegovy, Ozempic or Mounjaro will seek similar approval for use as treatment of sleep apnea. But, Dr. Zallek says people also need to talk with their provider and weigh the side effects with the benefits. Some of the side effects of the GLP1s include nausea, vomiting, diarrhea, delayed gastric emptying, low blood sugar, fatigue, and more serious complications such as gallstone disease, and pancreatitis.

As they say in the ads, “Ask your doctor if it's right for you."

Dr. Sarah Zallek

We’re in a time right now that Jason Bill, MD, an interventional gastroenterologist with OSF HealthCare calls an “obesity epidemic.”

Data from the Centers for Disease Control & Prevention (CDC) would back up that claim, stating that more than 100 million adults in the U.S. are obese. The prevalence of obesity increased over 11% when comparing statistics gathered from 1999-2000 to statistics from 2017-March 2020. In the earlier timeframe, obesity prevalence was 30.5%. The latest data showed obesity skyrocketed to 41.9%.

Tis the reason for countless “magical” weight loss drugs popping up on commercials, food-prep companies offering specials and zero-calorie drinks lining store shelves. But there’s no real sign of promise yet that America’s obesity problem is slowing down. This leaves many frustrated by the never-ending struggle of trying to eat healthily while working out, and not seeing any progress.

If you’re in that demographic, you’re not alone, and there may be a newer option to consider.

Introducing endoscopic bariatric procedures

In the last six to 12 months, Dr. Bill and his team at OSF HealthCare have started performing endoscopic bariatric procedures, a minimally invasive option to help patients lose weight. 

Dr. Bill says this option is perfect for those who either don’t qualify for bariatric surgery or for those who qualify but just do not want to undergo surgical intervention. His team is able to offer two different procedures:  Endoscopic Sleeve gastroplasty and trans-oral outlet reduction. 

"I think the patients that do the best are patients who have a body mass index (BMI) of 30-40 motivated and active, but just not getting to where they want to go with their standard diet and exercise,” Dr. Bill says. "We do everything through the mouth with our endoscopes. We take a camera to the stomach and use an endoscopic device that goes on the tip of the endoscope to run sutures and decrease the volume of the stomach. These are restrictive procedures, with the sleeve gastroplasty we are reducing the volume of the stomach by about 70 percent." 

Another option Dr. Bill’s team offers is called outlet reduction.

“It’s been really nice for patients who have had bariatric surgery and now are a few years out, but they start noticing they feel hungry or are gaining weight," Dr. Bill says. "We use that same suturing device and narrow down that prior opening that has stretched out over time." 

Minimally invasive means minimal recovery time. Patients go under general anesthesia, undergo the procedure, and then go home the same day. Dr. Bill says side effects are minimal as well. You might have some nausea and stomach discomfort for two to three days. However, the symptoms after the outlet reduction are even less severe, leaving patients energized and ready to get back on their weight loss journey.

How could endoscopic bariatrics and weight loss medicine connect?

"I think they should be used together. I think patients who will do best are those that undergo either surgical or endoscopic weight loss procedures initially.  Then, during their follow up consider starting a medication such as Mounjaro or Wegovy that can result in more robust weight loss,” Dr. Bill says. 

‘Take the lifestyle change head on’

The endoscopic weight loss procedure isn’t a get-out-of-jail free card to return to poor eating habits. It’s also not an excuse to cancel that gym membership or give up on daily exercise.

"The follow up after the procedure is probably as important, if not more important than the procedure itself. The procedure is likely to be successful, because your team is highly skilled, but the rest of the success is built on the patient’s motivation, diet, and exercise since it's a lifestyle change. They have to take that head on otherwise the procedure is not going to work,” Dr. Bill says.

These procedures are generally covered by Medicare and Medicaid. However, it’s hit or miss right now with other commercial payers. Dr. Bill’s team collaborates with the weight loss management team at the RiverPlex in downtown Peoria to get patients prepared for a procedure, and you’ll always know ahead of time whether insurance will cover your procedure.

If an endoscopic bariatric procedure sounds like something that would benefit you, you can call OSF Medical Group – Gastroenterology at 309-308-5900.

Video Interview Clips

An injectable prescription medication for adults with Type 2 diabetes is being hailed in Hollywood as a weight-loss drug, too.

Ozempic has been steadily in the headlines for months and became the butt of comedian Jimmy Kimmel at the 2023 Academy Awards when he joked, “When I look around this room I can’t help but wonder, ‘Is Ozempic right for me?”

Ozempic’s website – and its advertising - says the medicine is used “along with diet and exercise to improve blood sugar” and that “you should ask your healthcare provider if Ozempic is right for you.” Rachel Fehl, an advanced practice registered nurse at OSF Weight Management, agrees. She also says to make sure the drug you might take for weight loss is approved by the U.S. Food and Drug Administration (FDA).

“There are a lot of telehealth companies doing weight loss right now. You may notice you can get semaglutide (Ozempic) online for a much cheaper price. It’s going to range (around) $1,200 a month for the actual medication, but there are some pharmacies compounding it for much less. I would not recommend those compounded formulations, they’re not being regulated right now,” Fehl says.

Meta Rask, manager of the OSF Weight Management Center in Peoria, says the clinic focuses on healthy lifestyles, not trendy diets.

“We don’t focus on fad diets,” Rask says. “We truly focus on being healthy and meeting a patient’s needs where they’re at. We then help them figure out what disciplinary team is going to be able to help them meet those goals.”

While the OSF Weight Management Center sometimes does recommend a weight-loss drug alongside exercise and healthy eating, Rask says you need to work with the team to figure out a plan that works for you.

“We have nurses, we have a physician and we have registered dietitians and exercise physiologists,” Rask says. “They work together to meet patients one-on-one to do an assessment. They’re going to find out what that patient is looking for and what their barriers are.”

Fehl adds that everyone’s weight loss journey is different, and so is the response from OSF Weight Management providers.

“For some of our patients, we do utilize FDA-approved anti-obesity medications. Those do include some of the GLP-1 medications, similar to Ozempic, for the appropriate patient,” Fehl says.

Below are some tips if you are interested in beginning your weight loss journey.

1. Control carbohydrates: Specifically processed carbohydrates and caloric beverages. Just one can of regular soda contains more than the daily maximum amount of recommended sugar for men and women. 
2. Prioritize protein: Try to include protein with all meals and snacks. Protein helps us to feel full faster and for longer and can also reduce post meal blood sugar spikes.
3. Schedule Sleep: Getting less than seven hours or more than nine hours of sleep can both contribute to weight gain.
4. Take a break: This applies both to doing activities that reduce stress as well as giving our body a break from food. Find a meditation or breathing exercise you can add to your day to reduce cortisol production that can stimulate fat storage. Try to incorporate a 12 hour overnight fast (unless you have a medical condition that would not allow this). This practice can reduce gastrointestinal symptoms as well as allow for more use of stored fats for fuel.
5. Request a Referral: Ask your primary care provider or other provider for a referral to OSF Weight Management if you need some help getting started. The center’s goal is to help you change your lifestyle to one that allows you to reach your goals and improve overall health.  

Video Interview Clips

From Elon Musk to TikTokers, ongoing social media chatter claims drugs like Ozempic, Mounjaro and Wegovy are the magic way to weight loss.

There’s good news, says Aminat Ogun, MD, a family medicine physician at OSF HealthCare in Champaign, Illinois. Those drugs can help you lose weight when prescribed by a doctor under specific circumstances and paired with diet and exercise.

The more important bad news? There’s no magic, one-size-fits-all drug that will by itself cause you to shed pounds. And if someone on social media is claiming so, they’re wrong.

Dr. Ogun says Ozempic, Mounjaro and Wegovy are from the same family of medicine. They are usually prescribed to people with Type 2 diabetes.

“It increases the insulin in the body, which helps bring glucose into the cells,” Dr. Ogun explains.

The medications also slow food leaving your stomach and suppress appetite.

Once the drugs became more well known, Dr. Ogun says people found, not surprisingly, that weight loss was a side effect and began prescribing them for that purpose under specific circumstances. She says the patient should have a body mass index (BMI) greater than 30 or a BMI greater than 27 with a chronic condition like diabetes, hypertension or hyperlipidemia.

But even if you meet those guidelines, Dr. Ogun says you should talk with your doctor about whether a weight loss drug is right for you or whether simply changing habits can get the results you want.

For one, Ozempic, Mounjaro and Wegovy are expensive and may not be covered by insurance.

Also, the U.S. Food and Drug Administration reports a shortage of Ozempic and Wegovy. So Dr. Ogun says doctors may be less likely to prescribe the drugs for weight loss when diabetics may have a more critical need.

And like any other medication, there is a list of side effects.

“Abdominal pain, nausea, vomiting, diarrhea and constipation are possible,” Dr. Ogun says. “There are also hypersensitivity side effects like angioedema and an anaphylaxis reaction. It’s also been known to cause kidney injury or pancreatitis.”

Lately, the term “Ozempic face” has been trending on social media, describing a hollowed-out appearance due to quick weight loss.

One last piece of advice you’ll hear doctors give over and over: don’t rely on social media for health tips. If you find a tip that might benefit you, talk to your doctor before starting any treatment.

“The good thing about social media is that it allows a lot of people to receive a variety of information all at once,” Dr. Ogun says. “The downside: is it a credible source?”

Find a primary care provider on the OSF HealthCare website.

Interview clips